Cencora increases FY25 adjusted EPS view to $15.25-$15.55 from $15.15-$15.45

Raises FY25 revenue view to 8%-10% from 7%-9%. Consensus is for FY25 EPS $15.20 and for revenue $319.54B.Cencora (COR) updated its FY25 guidance to better reflect the continued momentum in the U.S. Healthcare Solutions reportable segment. The Company now expects: U.S. Healthcare Solutions revenue growth to be in the range of 9%-11%, from the previous range of 7%-9%; International Healthcare Solutions revenue growth to be in the range of 4%-5%, from the previous range of 7%-9%.